http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107759532-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f68ddaa0ddd894016af217422d657c22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ad2b4451a3b81d1c064e70eab49e86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34e208ebe657fdd286fd0f0987ce838f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19a7065cee4c12eaf18a36ee848541e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2cf900200e2d2c90cf6904e44c76952
publicationDate 2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107759532-A
titleOfInvention A kind of benzoxazole-2-ethyl oxime derivative, its preparation method and application
abstract The present invention provides a kind of benzoxazole-2-ethyl oxime derivative, as shown in formula (I) or formula (II); Wherein, X 1 and X 2 are each independently selected from NH or O; R 1 and R3 are each independently selected from H, F, Br or Cl ; R2 is selected from C1~C10 alkyl, substituted C1~C10 alkyl, phenyl or substituted phenyl; the substituted C1~C10 The substituent of the alkyl group is selected from phenyl or halogen. Compared with the prior art, the benzoxazole-2-ethyloxime derivatives shown in the formula (I) or formula (II) provided by the invention can significantly reduce the acute gouty arthritis rat ankle joint Swelling degree and serum uric acid level, it has good dual inhibitory activity of NLRP3 and TLR4 at the same time, the effect is higher than that of positive control dexamethasone, and can be used to prepare medicines for treating hyperuricemia or acute gouty arthritis, with few side effects and high safety .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110885318-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110885318-A
priorityDate 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105601571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006189668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010036905-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467622352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467396599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467653394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466778449

Total number of triples: 26.